|
Nanostring Technologies Inc (NASDAQ: NSTG) |
|
Nanostring Technologies Inc
NSTG's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Nanostring Technologies Inc growth rates, revenue grew
by 62.79 % in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 288
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -8 %
Nanostring Technologies Inc net loss increased from $-37 millions, to $-37 millions in III. Quarter 2023,
• More on NSTG's Growth
|
|
Nanostring Technologies Inc realized a net loss in trailing twelve months.
Nanostring Technologies Inc realized cash reduction of $ -0.48 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.03.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.85.
• More on NSTG's Valuation
|
|
|
|
|
Nanostring Technologies Inc realized net loss in trailing twelve months.
Nanostring Technologies Inc realized cash outflow of $ -0.48per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.03.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.85.
• More on NSTG's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com